Paras Healthcare IPO Allotment Status: Steps To Check Application Status; GMP Hints At 1.30% Premium Listing

Paras Healthcare IPO Allotment Status: This pharma company is carrying the allotment status of its Rs 1,450 crore, which closed last week. Investors can view their application status either on BSE, NSE or the registrar of the IPO, MUFG Intime India. However, the latest grey market premium (GMP) is currently signalling a muted or 1.30% premium listing on stock exchanges. Paras Healthcare is expected to debut on BSE and NSE on October 28, 2026.

Paras Healthcare IPO Allotment Status Today

There are several methods to check the allotment status of Paras Healthcare IPO such as BSE, NSE and MUFG. PAN card, application number or Demat account number will be critical to view your application and allotted shares.

How To Check Paras Healthcare IPO Allotment Status At MUFG Intime:

Step 1: CLICK on the official link of MUFG Intime IPO allotment status. Direct Link Is Below:

https://in.mpms.mufg.com/Initial_Offer/public-issues.html

Step 2: Select the company name Paras Healthcare IPO

Step 3: Enter either PAN number, application number, DP/Client number, account number, or IFSC code to proceed with the procedure.

Step 4: Click on Submit. The status of your application will appear accordingly.

How To Check Paras Healthcare IPO Allotment Status On BSE:

Step 1: Click on the main page of IPO allotment status of BSE. Direct Link Below:

https://www.bseindia.com/investors/appli_check.aspx

Step 2: Select the issue type 'Equity'.

Step 3: Enter issue name 'Paras Healthcare Ltd'.

Step 4: Enter either Application No or PAN Card number. Then enter captcha code and SUBMIT.

How To Check Paras Healthcare IPO Allotment Status On NSE:

Step 1: Click On NSE's 'Verify IPO Bids' page. Direct Link Below:

https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids

Step 2: Select the issue type 'Equity & SME IPO Bid Details'.

Step 3: Select the issue symbol, which is 'PARASHLTH'.

Step 4: Enter PAN card and Application number before clicking on
SUBMIT.

Paras Healthcare IPO GMP Today

Paras Healthcare IPO last recorded Grey Market Premium (GMP) is ₹9, updated on Oct 26, 2026 02:02:02 PM. With an upper price band of Rs 693.00, the estimated listing price for Paras Healthcare IPO is Rs 702 (cap price + today's GMP). This indicates an expected listing gain for Paras Healthcare IPO of 1.30%, as per Investor Grain.

Paras Healthcare IPO Credit Of Shares:

After identifying the eligible shareholders, the company will credit the allotted shares in demat account on October 27. Also, whose application is rejected will get a refund on Tuesday as well.

Paras Healthcare IPO Listing Predictions

As of now, the predicted listing price for Paras Healthcare is Rs 702, compared to issue price of Rs 693 apiece. The listing will take place on October 28, 2026.

Paras Healthcare IPO opened from Rs October 21st to October 23rd, at a price band of Rs 660 per share to Rs 693 per share. On the final day of the IPO, Paras Healthcare subscribed by 2.34 times.

According to Religare Broking's IPO note, the company has demonstrated good growth in its operating income and operating earnings over the years, reflecting improving business performance. It holds a decent position among peers, supported by rising bed capacity, improving occupancy and a strong regional presence, particularly in Tier-2 cities. Expansion plans provide further growth potential. With consistent business growth, improving operational performance and opportunities.

Incorporated in 1987, Paras Healthcare Limited is a clinical specialty-led hospital chain operating under the "Paras Health" brand across North India, Bihar and Jharkhand. As of June 30, 2026, it operated eight hospitals with 2,211 beds across eight cities. Its key specialties include cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics and renal sciences, contributing 75.3% of FY26 revenue. With over 20 years of operating history, the company plans to expand through new hospitals in Gurugram and Ludhiana, targeting 3,011 beds by March 2028.